Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
ZVRA holding history
Zevra Therapeutics, Inc. in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZVRA overviewAll 13F holders of ZVRAFull Q4 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q3 2024 | 1,000 | $6.94K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,000 | $4.90K | <0.1% | −1,000−50.0% | Reduced | Holders |
| Q1 2024 | 2,000 | $11.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,000 | $13.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,000 | $9.64K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,000 | $10.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,000 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,000 | $9.18K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,000 | $12.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,000 | $8.92K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,000 | $10.1K | <0.1% | −225−10.1% | Reduced | Holders |
| Q4 2021 | 2,225 | $19.4K | <0.1% | – | No prior filing | Holders |